Ondansetron Hydrochloride Solution
Product Images NDC 36000-012

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 36000-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (992e78b1 Bd2c 4e54 8a3f 425e8aea8542 01)

Chemical structure of Ondansetron Hydrochloride shown as a two-dimensional molecular diagram including a fused tricyclic ring system, a ketone group, and an imidazole moiety with associated hydrochloride hydrate formula (HCl·2H2O).*

FDA Label Image

Package Label – Principal Display Panel – 20 mL (992e78b1 Bd2c 4e54 8a3f 425e8aea8542 02)

FDA Label Image

Package Label – Principal Display Panel – 2 mL (992e78b1 Bd2c 4e54 8a3f 425e8aea8542 03)

Label for Ondansetron Injection, USP 4 mg/2 mL (2 mg/mL) in a sterile single-use vial, labeled for intravenous or intramuscular injection. Manufactured for Baxter Healthcare Corporation, Deerfield, IL, and by Baxter Pharmaceuticals India Private Ltd. The vial size is 2 mL. The label includes a barcode and manufacturing/expiration details with lot and batch fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.